Literature DB >> 34599371

[Intraoperative partial breast irradiation with electrons (ELIOT) compared to conventionally fractionated whole-breast irradiation of early-stage invasive breast cancer after breast-conserving surgery: long-term data from a prospective randomised trial].

Gerd Fastner1, Roland Reitsamer2, Christoph Gaisberger3, Markus Stana3, Felix Sedlmayer3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34599371     DOI： 10.1007/s00066-021-01848-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  20 in total

1.  How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.

Authors:  Maria Cristina Leonardi; Patrick Maisonneuve; Mauro Giuseppe Mastropasqua; Anna Morra; Roberta Lazzari; Nicole Rotmensz; Claudia Sangalli; Alberto Luini; Umberto Veronesi; Roberto Orecchia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-13       Impact factor: 7.038

2.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.

Authors:  Csaba Polgár; János Fodor; Tibor Major; Zoltán Sulyok; Miklós Kásler
Journal:  Radiother Oncol       Date:  2013-06-03       Impact factor: 6.280

3.  External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.

Authors:  Timothy J Whelan; Jim A Julian; Tanya S Berrang; Do-Hoon Kim; Isabelle Germain; Alan M Nichol; Mohamed Akra; Sophie Lavertu; Francois Germain; Anthony Fyles; Theresa Trotter; Francisco E Perera; Susan Balkwill; Susan Chafe; Thomas McGowan; Thierry Muanza; Wayne A Beckham; Boon H Chua; Chu Shu Gu; Mark N Levine; Ivo A Olivotto
Journal:  Lancet       Date:  2019-12-05       Impact factor: 79.321

4.  Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.

Authors:  Candace Correa; Eleanor E Harris; Maria Cristina Leonardi; Benjamin D Smith; Alphonse G Taghian; Alastair M Thompson; Julia White; Jay R Harris
Journal:  Pract Radiat Oncol       Date:  2016-09-17

5.  Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.

Authors:  Lorenzo Livi; Icro Meattini; Livia Marrazzo; Gabriele Simontacchi; Stefania Pallotta; Calogero Saieva; Fabiola Paiar; Vieri Scotti; Carla De Luca Cardillo; Paolo Bastiani; Lorenzo Orzalesi; Donato Casella; Luis Sanchez; Jacopo Nori; Massimiliano Fambrini; Simonetta Bianchi
Journal:  Eur J Cancer       Date:  2015-01-17       Impact factor: 9.162

6.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.

Authors:  Umberto Veronesi; Roberto Orecchia; Patrick Maisonneuve; Giuseppe Viale; Nicole Rotmensz; Claudia Sangalli; Alberto Luini; Paolo Veronesi; Viviana Galimberti; Stefano Zurrida; Maria Cristina Leonardi; Roberta Lazzari; Federica Cattani; Oreste Gentilini; Mattia Intra; Pietro Caldarella; Bettina Ballardini
Journal:  Lancet Oncol       Date:  2013-11-11       Impact factor: 41.316

7.  Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial.

Authors:  Icro Meattini; Livia Marrazzo; Calogero Saieva; Isacco Desideri; Vieri Scotti; Gabriele Simontacchi; Pierluigi Bonomo; Daniela Greto; Monica Mangoni; Silvia Scoccianti; Sara Lucidi; Lisa Paoletti; Massimiliano Fambrini; Marco Bernini; Luis Sanchez; Lorenzo Orzalesi; Jacopo Nori; Simonetta Bianchi; Stefania Pallotta; Lorenzo Livi
Journal:  J Clin Oncol       Date:  2020-08-24       Impact factor: 44.544

8.  5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

Authors:  Vratislav Strnad; Oliver J Ott; Guido Hildebrandt; Daniela Kauer-Dorner; Hellen Knauerhase; Tibor Major; Jaroslaw Lyczek; Jose Luis Guinot; Jürgen Dunst; Cristina Gutierrez Miguelez; Pavel Slampa; Michael Allgäuer; Kristina Lössl; Bülent Polat; György Kovács; Arnt-René Fischedick; Thomas G Wendt; Rainer Fietkau; Marion Hindemith; Alexandra Resch; Anna Kulik; Leo Arribas; Peter Niehoff; Fernando Guedea; Annika Schlamann; Richard Pötter; Christine Gall; Martina Malzer; Wolfgang Uter; Csaba Polgár
Journal:  Lancet       Date:  2015-10-19       Impact factor: 79.321

9.  Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.

Authors:  Roberto Orecchia; Umberto Veronesi; Patrick Maisonneuve; Viviana Enrica Galimberti; Roberta Lazzari; Paolo Veronesi; Barbara Alicja Jereczek-Fossa; Federica Cattani; Claudia Sangalli; Alberto Luini; Pietro Caldarella; Marco Venturino; Daniele Sances; Stefano Zurrida; Giuseppe Viale; Maria Cristina Leonardi; Mattia Intra
Journal:  Lancet Oncol       Date:  2021-04-09       Impact factor: 41.316

10.  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Authors:  Charlotte E Coles; Clare L Griffin; Anna M Kirby; Jenny Titley; Rajiv K Agrawal; Abdulla Alhasso; Indrani S Bhattacharya; Adrian M Brunt; Laura Ciurlionis; Charlie Chan; Ellen M Donovan; Marie A Emson; Adrian N Harnett; Joanne S Haviland; Penelope Hopwood; Monica L Jefford; Ronald Kaggwa; Elinor J Sawyer; Isabel Syndikus; Yat M Tsang; Duncan A Wheatley; Maggie Wilcox; John R Yarnold; Judith M Bliss
Journal:  Lancet       Date:  2017-08-02       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.